Qianhai Health Holdings Limited (HKG:0911)
0.2900
0.00 (0.00%)
At close: Feb 13, 2026
Qianhai Health Holdings Revenue
Qianhai Health Holdings had revenue of 340.85M HKD in the half year ending June 30, 2025, with 0.28% growth. This brings the company's revenue in the last twelve months to 553.58M, down -40.37% year-over-year. In the year 2024, Qianhai Health Holdings had annual revenue of 519.70M, down -45.94%.
Revenue (ttm)
553.58M
Revenue Growth
-40.37%
P/S Ratio
0.09
Revenue / Employee
39.54M
Employees
14
Market Cap
49.14M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 519.70M | -441.59M | -45.94% |
| Dec 31, 2023 | 961.29M | -1.00B | -51.00% |
| Dec 31, 2022 | 1.96B | 1.68B | 592.21% |
| Dec 31, 2021 | 283.40M | -477.32M | -62.75% |
| Dec 31, 2020 | 760.72M | 172.91M | 29.42% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Interlong Bio-technique Company | 1.09B |
| Kontafarma China Holdings | 891.73M |
| Wai Yuen Tong Medicine Holdings | 721.27M |
| PuraPharm Corporation | 346.76M |
| Tianda Pharmaceuticals | 310.50M |
| Fusen Pharmaceutical Company | 264.08M |
| Sanai Health Industry Group Company | 104.88M |
| Extrawell Pharmaceutical Holdings | 52.65M |